Cargando…

Estimating time and transportation costs associated with lung cancer screening and diagnostic lung procedures in Taiwan: a cross-sectional survey in a medical centre

OBJECTIVES: Earlier research has evaluated the non-medical costs after lung cancer diagnosis. This study estimated the time costs and transportation costs associated with low-dose CT (LDCT) screening and diagnostic lung procedures in Taiwan. DESIGN: Cross-sectional study. SETTING: A tertiary referra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chi-Hao, Ku, Li-Jung Elizabeth, Lin, Chien-Yu, Chung, Ta-Jung, Liu, Hui-Ju, Chao, Ting-Hsing, Yang, Szu-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008383/ https://www.ncbi.nlm.nih.gov/pubmed/36898750 http://dx.doi.org/10.1136/bmjopen-2022-070647

Ejemplares similares

Downstream Complications and Healthcare Expenditure after Invasive Procedures for Lung Lesions in Taiwan
por: Yang, Szu-Chun, et al.
Publicado: (2021)

Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007–2017
por: Huang, Shao-Yi, et al.
Publicado: (2020)

Out-of-pocket costs and productivity losses in haemodialysis and peritoneal dialysis from a patient interview survey in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2019)

Costs of surgical procedures in Indian hospitals
por: Chatterjee, Susmita, et al.
Publicado: (2013)

Economic costs of automated and continuous ambulatory peritoneal dialysis in Taiwan: a combined survey and retrospective cohort analysis
por: Tang, Chao-Hsiun, et al.
Publicado: (2017)

Overweight and obesity on the island of Ireland: an estimation of costs
por: Dee, Anne, et al.
Publicado: (2015)

Direct and indirect healthcare costs of lung cancer CT screening in Denmark: a registry study
por: Jensen, Manja Dahl, et al.
Publicado: (2020)

Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy
por: Khan, Iftekhar, et al.
Publicado: (2015)

Prevalence-based, disease-specific estimate of the social cost of smoking in Singapore
por: Cher, Boon Piang, et al.
Publicado: (2017)

Cost-effectiveness analysis of pembrolizumab plus chemotherapy for previously untreated metastatic non-small cell lung cancer in the USA
por: Zeng, Xiaohui, et al.
Publicado: (2019)

Determining cost-effectiveness of lung cancer screening in urban Chinese populations using a state-transition Markov model
por: Sun, Chengyao, et al.
Publicado: (2021)

Camrelizumab in patients with advanced non-squamous non-small cell lung cancer: a cost-effective analysis in China
por: Xie, Qian, et al.
Publicado: (2022)

The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke
por: van Eeden, M, et al.
Publicado: (2015)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol
por: Shen, XingRong, et al.
Publicado: (2018)

Diagnostic and Therapeutic Costs of Patients With a Diagnosis of or Suspected Coronavirus Disease in Iran
por: Ebrahimipour, Hosein, et al.
Publicado: (2022)

Estimating the costs of blindness and moderate to severe visual impairment among people with diabetes in India
por: Redding, Stuart, et al.
Publicado: (2023)

Cost-effectiveness of a patient-centred approach to managing multimorbidity in primary care: a pragmatic cluster randomised controlled trial
por: Thorn, Joanna, et al.
Publicado: (2020)

Cost-effectiveness analysis of serplulimab combined with chemotherapy in the treatment of extensive-stage small-cell lung cancer from the perspective of the healthcare system in China
por: Long, Yunchun, et al.
Publicado: (2023)

Cost-effectiveness analysis of adding ramucirumab to the first-line erlotinib treatment for untreated EGFR-mutated metastatic non-small cell lung cancer in China
por: Liu, Qiao, et al.
Publicado: (2020)

Cost estimator's reference manual
por: Johannes, James D, et al.
Publicado: (1995)

Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls
por: Aebersold, Helena, et al.
Publicado: (2023)

Data to estimate costs of producing grass-clover silages
por: Flaten, Ola, et al.
Publicado: (2020)

Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study
por: Schofield, D., et al.
Publicado: (2020)

Estimating the cost-effectiveness and return on investment of the Victorian Cardiac Outcomes Registry in Australia: a minimum threshold analysis
por: Lee, Peter, et al.
Publicado: (2023)

The Impact of the Synergistic Effect of Temperature and Air Pollutants on Chronic Lung Diseases in Subtropical Taiwan
por: Wu, Da-Wei, et al.
Publicado: (2021)

Smoking Status Among Patients With Newly Diagnosed Lung Cancer in Taiwan
por: YANG, Chia-Chen, et al.
Publicado: (2019)

Analysis on personnel costs and working time for implementing a more person-centred care approach: a case study with embedded units in a Swedish region
por: Gyllensten, Hanna, et al.
Publicado: (2023)

A two-part model to estimate inpatient, outpatient, prescribing and care home costs associated with atrial fibrillation in Scotland
por: Ciminata, Giorgio, et al.
Publicado: (2020)

Using variation between countries to estimate demand for Cochrane reviews when access is free: a cost–benefit analysis
por: Jacobs, Perke, et al.
Publicado: (2021)

Incidence of Lung Adenocarcinoma by Age, Sex, and Smoking Status in Taiwan
por: Chien, Li-Hsin, et al.
Publicado: (2023)

Estimation method for distance cost to access medical services: Policy and patient privacy implications in Taiwan
por: Guo, Siao-Jing, et al.
Publicado: (2022)

Estimating and examining the costs of inpatient diabetes care in an Irish Public Hospital
por: Friel, Kathleen M., et al.
Publicado: (2021)

A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors
por: Jacklin, Paul Brian, et al.
Publicado: (2017)

Data obtained with a novel approach to estimate installment loan acquisition costs
por: Lukongo, Onyumbe Enumbe B., et al.
Publicado: (2018)

Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan
por: Chen, Po-Chuan, et al.
Publicado: (2015)

Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data
por: Lohan, Christoph, et al.
Publicado: (2023)

Utilization and medical costs of outpatient rehabilitation among children with autism spectrum conditions in Taiwan
por: Li, Hsing-Jung, et al.
Publicado: (2019)

Brucellosis, Taiwan, 2011
por: Chuang, Yu-Chung, et al.
Publicado: (2011)

Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study
por: Barrenetxea, Gorka, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mv5c8ak1q2h0p77hdiis2nfmjq